approval · primary record
LANDIOLOL HYDROCHLORIDE
FDA · NDA · 2026-02-13
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-02-13 |
| Brand | RAPIBLYK |
| Sponsor | AOP HLTH US |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:41.980Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:LANDIOLOL HYDROCHLORIDE:2026-02-13
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.